Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment…
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan…
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes…
Brickell Biotech Inc (NASDAQ: BBI) Announces Dosing of First Subject with…
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:MBRX
Tag: NASDAQ:MBRX
Moleculin Biotech Inc. (NASDAQ: MBRX) Announces Preliminary Results Of Study Evaluating...
Gavins Felicity
-
January 6, 2022
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Granted Three Rare Paediatric Disease Designations For...
Ward Sport
-
December 4, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Receives Rare Paediatric Disease Designation For WP1066...
Matt Wade
-
December 3, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Enters Into an Agreement with Sterling Pharma...
Gavins Felicity
-
July 23, 2020
0
Moleculin Biotech Inc. (NASDAQ:MBRX) Submits Expansion Request For Annamycin Study Sites...
Kate Hudson
-
June 15, 2020
0
Recent Post
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...
Gavins Felicity
-
July 5, 2022
0
CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
July 4, 2022
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...
July 1, 2022
Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...
June 30, 2022
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...
June 30, 2022